GLP-1s & Microdosing

GLP-1s and Microdosing: Should You or Shouldn’t You?


Posted on

by Arianne Missimer

GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are everywhere right now. They’ve been hailed as game-changers for weight management, diabetes, and even heart and liver health.

But what about microdosing—taking very small doses long-term? Is it safe? Effective? Or just another trend without evidence to back it up? Let’s break it down.

Rather watch or listen?

Youtube video

What GLP-1s Are and How They Work

GLP-1 stands for glucagon-like peptide 1, a hormone your gut releases after you eat. It communicates with several organs:

  • Pancreas: Signals insulin release and suppresses glucagon, lowering blood sugar.
  • Stomach: Slows emptying so you feel full longer.
  • Brain: Reduces appetite and cravings.
  • Heart, kidneys, liver: Helps decrease inflammation, oxidative stress, and fat buildup.

Here’s the catch: natural GLP-1 breaks down in just minutes. That’s why GLP-1 receptor agonists (like semaglutide and tirzepatide) were developed—longer-acting versions that extend these benefits.

What They’re FDA-Approved For

Currently, GLP-1 medications are approved for:

  • Type 2 diabetes
  • Obesity and weight management
  • Reducing cardiovascular risk in people with heart or kidney disease
  • MASH (metabolic-associated steatohepatitis), formerly called NASH, a type of fatty liver disease

Microdosing: What It Means

Microdosing usually refers to staying at a very low dose—say, 0.25 mg of semaglutide—long-term, rather than gradually increasing to the therapeutic dose. Some even split doses into tiny injections multiple times per week.

It’s become a trend, especially through compounding pharmacies. But here’s the truth: there are no clinical trials or guidelines that support microdosing GLP-1s.

Who Should Avoid GLP-1s

These medications are powerful, but not for everyone. They’re not recommended if you have:

  • Gastroparesis or severe GI conditions
  • A personal or family history of medullary thyroid carcinoma or MEN2 genetic syndrome
  • A history of pancreatitis
  • Pregnancy or are breastfeeding
  • Diabetic retinopathy (risk of worsening with rapid glucose drops)

Always share your full health history with your provider—transparency is critical for safe recommendations.

Microdosing vs. Standard Dosing: What the Evidence Says

Here’s the bottom line:

  • Low doses can lead to some weight loss, but the strongest, most consistent benefits—significant weight reduction, heart and kidney protection, liver improvements—were shown at therapeutic doses.
  • No studies show that microdosing gives the same outcomes.
  • Side effects like nausea, gallbladder issues, or rare pancreatitis can still occur at lower doses.

What is supported by research? Slower titration—staying at each step longer so your body adjusts—while still moving toward an effective therapeutic dose.

Should You or Shouldn’t You?

If your goal is meaningful weight loss or protecting your heart, kidneys, or liver, evidence points to therapeutic dosing—not indefinite microdosing.

If you’re struggling with side effects, ask your provider about slower titration instead.

If you’re considering compounded GLP-1s, make sure they’re true FDA-approved formulations—not unstudied salt versions.

And if your health history puts you at high risk (thyroid cancer, pancreatitis, pregnancy), GLP-1s are not for you.

Lifestyle Still Matters

For those chasing only mild weight loss, take a hard look at lifestyle first:

  • Sleep: Do you have sleep apnea or poor sleep quality impacting metabolism?
  • Nutrition: Are you nourishing your body—not just eating less or more, but meeting your energy and micronutrient needs?
  • Exercise: Are you training in ways that support your body as it changes through your 30s, 40s, 50s, and beyond?

Behavioral changes are still the foundation. Medications can help, but they can’t replace lifestyle.

Final Thoughts

GLP-1s are powerful tools that mimic a hormone your body already makes—but how you use them matters.

Microdosing might sound appealing, but the evidence isn’t there. The proven benefits come from standard, evidence-based dosing with careful titration.

If you’re considering GLP-1s, have an honest conversation with your provider, share your full history, and weigh the pros and cons carefully.

Next Steps

If you found this helpful, please give it a like, share it, and subscribe to our YouTube channel, the Movement Paradigm, for weekly tips on mindset, nutrition, and movement. Our goal is to help you live your best life, heal, transform, and, more importantly, thrive.

Join Our Community

You can always join us in our app, the Movement Paradigm. Download it from Google or the App Store. We have lots of challenges every other month—everything from movement to the nervous system, nutrition, and so on. And we have a great community of people. 

You can also reach out to us for an individual appointment for functional medicine or holistic physical therapy. If you really want to get to the root cause, please reach out to us.

Other things that might interest you: